Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study

The indicated mechanisms of action of diacerein/rhein can reduce viral replication and mitigate the inflammatory response related to SARS-CoV-2. These findings are preliminary and require confirmation in clinical trials.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2024-10-07
DOI
https://doi.org/10.3389/fphar.2024.1402032
Citations
4
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
1.48

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study

Isabella Bonilha, Victor Corasolla Carregari, Wilson Nadruz, Lı́cio A. Velloso et al.
4 citations
Frontiers in Pharmacology
Long-Term Effects of COVID-19
1.48
article

Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study

Isabella Bonilha, Victor Corasolla Carregari, Wilson Nadruz, Lı́cio A. Velloso, Sean M. Davidson, Flávia Elisa Galdino, Deepak L. Bhatt, Marcelo A. Mori, Watson Loh, Joseane Morari, Helison Rafael Pereira do Carmo, Alessandro S. Farias, Daniel Martins‐de‐Souza, Gustavo Gastão Davanzo, Pedro Gonçalves de Oliveira, José Luiz Proença‐Módena, Stéfanie Primon Muraro, Filipe A. Moura, Lauar de Brito Monteiro, Pedro M. Moraes‐Vieira, Natália S. Brunetti, Andrei C. Spósito, Gabriela Fabiano de Souza, Derek M. Yellon, Guilherme Reis-de-Oliveira, Joaquim Barreto, Erica I. L. Gomes, Alejandro Rossel Castillo
article en
4 citations

Abstract

The indicated mechanisms of action of diacerein/rhein can reduce viral replication and mitigate the inflammatory response related to SARS-CoV-2. These findings are preliminary and require confirmation in clinical trials.

Frontiers in PharmacologyVol. 15
Brigham and Women's Hospital (US), Harvard University (US), Universidade Estadual de Campinas (UNICAMP) (BR), Mount Sinai Hospital (US), D’Or Institute for Research and Education (BR), Brazilian Synchrotron Light Laboratory (BR), Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Brazilian Center for Research in Energy and Materials (BR), Thrombolysis in Myocardial Infarction Study Group (US), University College London (GB), Icahn School of Medicine at Mount Sinai (US)
Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Universidade Estadual de Campinas
Openalex Percentile: Top 17%
Long-Term Effects of COVID-19
1.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.